Company intelligence / Profile preview

HeartWare International

Framingham, Massachusetts, United States

Ownership: Private
Employees: ~600
Development stage: Other

Overview

HeartWare developed and commercialized the HVAD System, the world's smallest full-support ventricular assist device (VAD) for treating advanced heart failure patients. The device was discontinued by Medtronic in June 2021 due to higher rates of stroke and mortality compared to Abbott's HeartMate 3, along with over 100 complaints involving pump failures, 14 patient deaths, and 13 explants.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on HeartWare International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HeartWare International.

Explore the full profile